As a true CDMO, Avéma is unique in the scope of its offerings, the depth of its experience and the extent of its capabilities. The fully-integrated environment at Avéma enables companies to bring solid and liquid dose products to market more quickly because it offers expertise at every stage of development from concept, through clinical trial support, through scale up, to commercial production. Avéma operates nine cGMP-compliant and FDA-registered locations in the United States, with research and development capabilities in our Miami facility.